2021 Q4 Form 10-Q Financial Statement
#000095017021003738 Filed on November 09, 2021
Income Statement
Concept | 2021 Q4 | 2021 Q3 | 2021 Q2 |
---|---|---|---|
Revenue | $1.616M | $1.159M | $482.0K |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $3.937M | $3.656M | $1.997M |
YoY Change | 487.61% | 766.35% | 361.2% |
% of Gross Profit | |||
Research & Development | $11.17M | $8.406M | $4.737M |
YoY Change | 1028.18% | 907.91% | 603.86% |
% of Gross Profit | |||
Depreciation & Amortization | $64.00K | $27.00K | $13.00K |
YoY Change | 611.11% | 2600.0% | 1200.0% |
% of Gross Profit | |||
Operating Expenses | $15.11M | $8.406M | $4.737M |
YoY Change | 812.75% | 907.91% | 603.86% |
Operating Profit | -$10.90M | -$6.252M | |
YoY Change | 768.07% | 465.28% | |
Interest Expense | $74.00K | $137.0K | $46.00K |
YoY Change | -103.4% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $137.0K | $46.00K | |
YoY Change | -103.4% | ||
Pretax Income | -$13.42M | -$10.77M | -$6.206M |
YoY Change | 710.63% | 757.17% | 152.28% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$13.42M | -$10.77M | -$6.206M |
YoY Change | 710.63% | 757.17% | 152.28% |
Net Earnings / Revenue | -830.2% | -928.9% | -1287.55% |
Basic Earnings Per Share | -$0.26 | ||
Diluted Earnings Per Share | -$324.0K | -$261.7K | -$618.5K |
COMMON SHARES | |||
Basic Shares Outstanding | 41.61M | 477.4K | 589.1K |
Diluted Shares Outstanding | 41.13M |
Balance Sheet
Concept | 2021 Q4 | 2021 Q3 | 2021 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $375.0M | $387.5M | $394.2M |
YoY Change | |||
Cash & Equivalents | $35.58M | $39.39M | $251.6M |
Short-Term Investments | $339.4M | $348.1M | $142.6M |
Other Short-Term Assets | $2.054M | $2.081M | $2.038M |
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | $0.00 | $0.00 | $400.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $377.0M | $389.6M | $396.6M |
YoY Change | 2247.27% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.412M | $1.118M | $215.0K |
YoY Change | 810.97% | ||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $392.0K | $140.0K | |
YoY Change | |||
Total Long-Term Assets | $2.805M | $1.496M | $215.0K |
YoY Change | 1709.68% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $377.0M | $389.6M | $396.6M |
Total Long-Term Assets | $2.805M | $1.496M | $215.0K |
Total Assets | $379.8M | $391.1M | $396.8M |
YoY Change | 2242.13% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.458M | $3.613M | $354.0K |
YoY Change | 474.3% | ||
Accrued Expenses | $3.779M | $2.030M | $2.286M |
YoY Change | 403.2% | ||
Deferred Revenue | $5.163M | $5.264M | $5.065M |
YoY Change | 164.77% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $12.80M | $12.47M | $9.205M |
YoY Change | 302.29% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $700.0K | $1.863M | $2.823M |
YoY Change | |||
Total Long-Term Liabilities | $700.0K | $1.863M | $2.823M |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $12.80M | $12.47M | $9.205M |
Total Long-Term Liabilities | $700.0K | $1.863M | $2.823M |
Total Liabilities | $13.50M | $14.33M | $12.03M |
YoY Change | 46.21% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$47.41M | -$34.00M | -$23.20M |
YoY Change | 221.67% | ||
Common Stock | $414.0M | $410.7M | $408.0M |
YoY Change | 409808.91% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $366.3M | $376.8M | $384.8M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $379.8M | $391.1M | $396.8M |
YoY Change | 2242.13% |
Cashflow Statement
Concept | 2021 Q4 | 2021 Q3 | 2021 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$13.42M | -$10.77M | -$6.206M |
YoY Change | 710.63% | 757.17% | 152.28% |
Depreciation, Depletion And Amortization | $64.00K | $27.00K | $13.00K |
YoY Change | 611.11% | 2600.0% | 1200.0% |
Cash From Operating Activities | -$10.48M | -$5.854M | -$6.204M |
YoY Change | 543.4% | 440.54% | 694.37% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.173M | -$77.00K | -$79.00K |
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $8.499M | -$205.5M | -$142.5M |
YoY Change | |||
Cash From Investing Activities | $7.326M | -$205.5M | -$142.6M |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 164.0K | -843.0K | 329.7M |
YoY Change | -96.4% | 2454.55% | 5893.76% |
NET CHANGE | |||
Cash From Operating Activities | -10.48M | -5.854M | -6.204M |
Cash From Investing Activities | 7.326M | -205.5M | -142.6M |
Cash From Financing Activities | 164.0K | -843.0K | 329.7M |
Net Change In Cash | -2.991M | -212.2M | 180.9M |
YoY Change | -202.29% | 18917.56% | 3732.51% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$10.48M | -$5.854M | -$6.204M |
Capital Expenditures | -$1.173M | -$77.00K | -$79.00K |
Free Cash Flow | -$9.308M | -$5.777M | -$6.125M |
YoY Change | 471.39% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001817713 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2021Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-40475 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Janux Therapeutics, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
82-2289112 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
11099 N. Torrey Pines Road, Suite 290 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
La Jolla | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92037 | ||
dei |
City Area Code
CityAreaCode
|
858 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
750-4700 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.001 par value per share | ||
dei |
Trading Symbol
TradingSymbol
|
JANX | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2021Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
41611510 | |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
39389000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7813000 | |
CY2021Q3 | us-gaap |
Short Term Investments
ShortTermInvestments
|
348118000 | |
CY2020Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | |
CY2021Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
0 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8000000 | |
CY2021Q3 | janx |
Prepaid Expenses And Other Current Assets Related Parties Current
PrepaidExpensesAndOtherCurrentAssetsRelatedPartiesCurrent
|
14000 | |
CY2020Q4 | janx |
Prepaid Expenses And Other Current Assets Related Parties Current
PrepaidExpensesAndOtherCurrentAssetsRelatedPartiesCurrent
|
0 | |
CY2021Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2081000 | |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
249000 | |
CY2021Q3 | us-gaap |
Assets Current
AssetsCurrent
|
389588000 | |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
16062000 | |
CY2021Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1118000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
155000 | |
CY2021Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
238000 | |
CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
0 | |
CY2021Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
140000 | |
CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
0 | |
CY2021Q3 | us-gaap |
Assets
Assets
|
391084000 | |
CY2021Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
5264000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1950000 | |
CY2021Q3 | janx |
Unvested Stock Liabilities
UnvestedStockLiabilities
|
1352000 | |
CY2020Q4 | janx |
Unvested Stock Liabilities
UnvestedStockLiabilities
|
52000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
212000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
16217000 | |
CY2021Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3613000 | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
428000 | |
CY2021Q3 | janx |
Accrued Liabilities Related Parties Current
AccruedLiabilitiesRelatedPartiesCurrent
|
0 | |
CY2020Q4 | janx |
Accrued Liabilities Related Parties Current
AccruedLiabilitiesRelatedPartiesCurrent
|
544000 | |
CY2021Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2030000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
751000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
0 | |
CY2021Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
12471000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3181000 | |
CY2021Q3 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
1840000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
6050000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
23000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
0 | |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
14334000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
9231000 | |
CY2021Q3 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
CY2021Q3 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
0 | |
CY2020Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
6838829 | |
CY2021Q3 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | |
CY2021Q3 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
6838829 | |
CY2020Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
6838829 | |
CY2021Q3 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
0 | |
CY2020Q4 | us-gaap |
Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
|
21709000 | |
CY2021Q3 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
0 | |
CY2020Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
21624000 | |
CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
0 | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
9000000 | |
CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
41611510 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1257736 | |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | |
CY2021Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
410680000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
100000 | |
CY2021Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
24000 | |
CY2021Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-10766000 | |
CY2020Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-1256000 | |
CY2021Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
41171963 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1046599 | |
CY2021Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
41000 | |
CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
0 | |
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-33995000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-14739000 | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
376750000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14638000 | |
CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
391084000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
16217000 | |
CY2021Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
1159000 | |
CY2020Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
0 | |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
2021000 | ||
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
0 | ||
CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8406000 | |
CY2020Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
834000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
15068000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2056000 | ||
CY2021Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3656000 | |
CY2020Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
422000 | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
6392000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1132000 | ||
CY2021Q3 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
12062000 | |
CY2020Q3 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
1256000 | |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
21460000 | ||
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
3188000 | ||
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10903000 | |
CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1256000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-19439000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3188000 | ||
CY2021Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
137000 | |
CY2020Q3 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
0 | |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
183000 | ||
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
0 | ||
CY2021Q3 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | |
CY2020Q3 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | ||
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
206000 | ||
CY2021Q3 | us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
0 | |
CY2020Q3 | us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
0 | |
us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
0 | ||
us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
-1735000 | ||
CY2021Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
137000 | |
CY2020Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
183000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1941000 | ||
CY2020Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-1256000 | |
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-19232000 | ||
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-5129000 | ||
CY2021Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.26 | |
CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.33 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.10 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-19256000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-5129000 | ||
CY2021Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
7000 | |
CY2020Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
0 | |
us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
24000 | ||
us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
0 | ||
CY2021Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-10759000 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-5.79 | ||
CY2021Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
41134102 | |
CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
943634 | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
17572807 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
885486 | ||
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14638000 | |
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
202171000 | ||
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
204137000 | ||
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
20000 | ||
us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
326000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3966000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
24000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-19256000 | ||
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
376750000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7944000 | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
4000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
32000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5129000 | ||
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13037000 | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
384795000 | |
CY2021Q3 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
148000 | |
CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2566000 | |
CY2021Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
7000 | |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10766000 | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
376750000 | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11809000 | |
CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
28000 | |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1256000 | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13037000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-19256000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-5129000 | ||
us-gaap |
Depreciation
Depreciation
|
49000 | ||
us-gaap |
Depreciation
Depreciation
|
4000 | ||
us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-3000 | ||
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | ||
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
206000 | ||
us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
0 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3966000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
32000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
114000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
0 | ||
us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
-0 | ||
us-gaap |
Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
|
-1735000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-8000000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
0 | ||
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
140000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
200000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | ||
janx |
Prepaid Expenses And Other Current Assets Includes Related Party Amounts
PrepaidExpensesAndOtherCurrentAssetsIncludesRelatedPartyAmounts
|
14000 | ||
janx |
Prepaid Expenses And Other Current Assets Includes Related Party Amounts
PrepaidExpensesAndOtherCurrentAssetsIncludesRelatedPartyAmounts
|
0 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1832000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-896000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | ||
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
0 | ||
janx |
Accounts Payable Includes Related Party Amounts
AccountsPayableIncludesRelatedPartyAmounts
|
0 | ||
janx |
Accounts Payable Includes Related Party Amounts
AccountsPayableIncludesRelatedPartyAmounts
|
50000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
2621000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
212000 | ||
janx |
Accrued Expenses Includes Related Party Amounts
AccruedExpensesIncludesRelatedPartyAmounts
|
-544000 | ||
janx |
Accrued Expenses Includes Related Party Amounts
AccruedExpensesIncludesRelatedPartyAmounts
|
195000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1107000 | ||
janx |
Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet
|
3000 | ||
janx |
Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet
|
0 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6495000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2740000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
309000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | ||
us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
370125000 | ||
us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
0 | ||
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
22145000 | ||
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
0 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-348289000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | ||
janx |
Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
|
0 | ||
janx |
Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
|
2500000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1646000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
4000 | ||
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
204167000 | ||
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
0 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
386360000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6971000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
31576000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
4231000 | ||
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
7813000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
658000 | |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
39389000 | |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
4889000 | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
202171000 | ||
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
0 | ||
janx |
Conversion Of Convertible Promissory Notes And Accrued Interest Into Shares Of Convertible Preferred Stock
ConversionOfConvertiblePromissoryNotesAndAccruedInterestIntoSharesOfConvertiblePreferredStock
|
0 | ||
janx |
Conversion Of Convertible Promissory Notes And Accrued Interest Into Shares Of Convertible Preferred Stock
ConversionOfConvertiblePromissoryNotesAndAccruedInterestIntoSharesOfConvertiblePreferredStock
|
8674000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
853000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
146000 | ||
janx |
Vesting Of Restricted Common Stock
VestingOfRestrictedCommonStock
|
326000 | ||
janx |
Vesting Of Restricted Common Stock
VestingOfRestrictedCommonStock
|
0 | ||
us-gaap |
Stock Issued1
StockIssued1
|
30000 | ||
us-gaap |
Stock Issued1
StockIssued1
|
6000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
24000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | ||
us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
256000 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
36455 | ||
us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
1700000 | ||
CY2021Q3 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
348118000 | |
us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
Company’s certificate of incorporation to effect a forward split of shares of the Company’s common stock on a one-for-1.281 basis, which was effected on June 4, 2021 (the “Forward Stock Split”). The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Forward Stock Split. The accompanying financial statements and notes to the financial statements give retroactive effect to the Forward Stock Split for all periods presented. | ||
us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
1.281 | ||
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-34000000.0 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">preparation of the Company’s financial statements requires it to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s financial statements and accompanying notes. The most significant estimates in the Company’s financial statements relate to estimates to complete the performance obligations and the estimated transaction price for collaboration revenue, accruals for research and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expenses, stock-based compensation and fair value measurements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of revenues and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates.</span></p> | ||
CY2020Q3 | us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
0 | |
CY2021Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
348094000 | |
CY2021Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
33000 | |
CY2021Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
9000 | |
CY2021Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
348118000 | |
CY2021Q3 | us-gaap |
Financing Receivable Accrued Interest Before Allowance For Credit Loss
FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss
|
28000000 | |
CY2021Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
303126000 | |
CY2021Q3 | janx |
Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
|
44992000 | |
CY2021Q3 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
0 | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
6.26 | ||
us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
0 | ||
CY2020Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
286000 | |
CY2021Q3 | janx |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
729000 | |
CY2020Q4 | janx |
Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
|
66000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
7.83 | ||
CY2021Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
517000 | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentrations of Risk</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:4.5pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. The Company maintains deposits in a federally insured financial institution in excess of federally insured limits. The Company has not experienced any losses in such account and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held.</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Company is also subject to credit risk from its accounts receivable. The Company generally does not perform evaluations of customers’ financial condition and generally does not require collateral. As of December 31, 2020 and September 30, 2021, all of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Company’s </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">accounts receivable, if any, relate to a single customer. For the three and nine months ended September 30, 2021, all of the Company’s revenue related to a single customer.</span> | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.43 | ||
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
477408 | |
CY2020Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
202655 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
457556 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
255473 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
1000000.0 | ||
CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
399000 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5995318 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8696000 | ||
CY2021Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1184000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
176000 | |
CY2021Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
66000 | |
CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
21000 | |
CY2021Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1118000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
155000 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
72673000 | |
CY2021Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
784000 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
5547447 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5547447 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | ||
CY2021Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
36500000 | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.59 | ||
CY2021Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2030000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
751000 | |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y3M18D | ||
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
22000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
220000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
242000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
7000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
235000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
212000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
23000 | |
CY2021Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y1M6D | |
CY2020 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
0 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1096533 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.47 | |
CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y3M21D | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
3214000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
5122685 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
10.43 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
635316 | ||
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
9.39 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y5M15D | ||
CY2021Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
72291000 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
9.39 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P9Y5M15D | ||
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
72673000 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5054747 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
7.33 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P9Y5M4D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.85 | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P10Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
CY2021Q2 | janx |
Percentage Of Number Of Common Stock Shares
PercentageOfNumberOfCommonStockShares
|
0.01 | |
CY2021Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2566000 | |
CY2020Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
28000 | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3966000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
32000 | ||
CY2020Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
211137 | |
CY2020Q4 | janx |
Unvested Stock Liabilities
UnvestedStockLiabilities
|
52000 | |
janx |
Share Based Compensation Arrangement By Share Based Payment Award Options Early Exercised Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExercisedShares
|
521896 | ||
janx |
Unvested Stock Liabilities Early Exercised Shares
UnvestedStockLiabilitiesEarlyExercisedShares
|
1626000 | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
293486 | ||
janx |
Unvested Stock Liabilities Vested Shares
UnvestedStockLiabilitiesVestedShares
|
326000 | ||
CY2021Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
439547 | |
CY2021Q3 | janx |
Unvested Stock Liabilities
UnvestedStockLiabilities
|
1352000 | |
CY2021Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
9749702 | |
CY2020Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
10077215 | |
CY2021Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
0 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8000000.0 | |
CY2021Q3 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y6M | |
us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.03 |